<p>Dr. Jeff Burns, Director of the University of Kansas Alzheimer's Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.</p>

Dr. Jeff Burns, Director of the University of Kansas Alzheimer's Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.

SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Share SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists

Sign up to save your podcasts

SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists

SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists

More shows like Neurology® Podcast

NEJM This Week

JAMA Clinical Reviews

Practical Neurology Podcast

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

JAMA Neurology Author Interviews

Core IM | Internal Medicine Podcast

Neurology Today in 5

Annals On Call Podcast

Navigating Neuropsychology

The Clinical Problem Solvers

Neurology Minute

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio